Cargando…

Treatment of Digital Ulcers and Reflux Oesophagitis in a Patient with Systemic Sclerosis: Increased Risk of Hepatotoxicity due to a Potential Drug-drug Interaction Between Bosentan and Vonoprazan

Detalles Bibliográficos
Autores principales:	KIMURA, Ryoko, SUGITA, Kazunari, SUGIHARA, Takaaki, ISOMOTO, Hajime, YAMAMOTO, Osamu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Publication of Acta Dermato-Venereologica 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455316/ https://www.ncbi.nlm.nih.gov/pubmed/34694420 http://dx.doi.org/10.2340/actadv.v101.439

Ejemplares similares

Vonoprazan in the management of erosive oesophagitis and peptic ulcer-induced medication: a systematic review
por: Chinzon, Décio, et al.
Publicado: (2021)

Use of vonoprazan for management of systemic sclerosis-related gastroesophageal reflux disease
por: Tabuchi, Maiko, et al.
Publicado: (2021)

Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease
por: Gotoh, Yasuhiko, et al.
Publicado: (2020)

Reflux Oesophagitis
por: Smith, P. M.
Publicado: (1990)

Novel Ultrastructural Findings of Blastic Plasmacytoid Dendritic Cell Neoplasm
por: Sugita, Kazunari, et al.
Publicado: (2021)

Effect of bosentan in pulmonary hypertension development in systemic sclerosis patients with digital ulcers
por: Castellví, Ivan, et al.
Publicado: (2020)

Drug–Drug Interaction between Tacrolimus and Vonoprazan in Kidney Transplant Recipients
por: Suzuki, Yoshiharu, et al.
Publicado: (2021)

There is no correlation between signs of reflux laryngitis and reflux oesophagitis in patients with gastro-oesophageal reflux disease symptoms
por: Zelenik, K., et al.
Publicado: (2017)

Impact of Vonoprazan Triple-Drug Blister Packs on H. pylori Eradication Rates in Japan: Interrupted Time Series Analysis
por: Deguchi, Hisato, et al.
Publicado: (2021)

Efficacy of Vonoprazan for Gastroesophageal Reflux Symptoms in Patients with Proton Pump Inhibitor-resistant Non-erosive Reflux Disease
por: Niikura, Ryota, et al.
Publicado: (2018)

Cytochrome P450-Based Drug-Drug Interactions of Vonoprazan In Vitro and In Vivo
por: Wang, Yiran, et al.
Publicado: (2020)

Bosentan monohydrate
por: Kaur, Manpreet, et al.
Publicado: (2012)

The Development of Foveolar-type Gastric Adenocarcinoma during Maintenance Therapy of Vonoprazan for Reflux Esophagitis
por: Saito, Masahiro, et al.
Publicado: (2020)

Digital ulcers secondary to Sneddon’s syndrome successfully treated with Bosentan: not only useful in Systemic Sclerosis
por: Barnini, Tommaso, et al.
Publicado: (2012)

Effectiveness of bosentan in the treatment of systemic sclerosis-related digital ulcers: Systematic review and meta-analysis
por: Hosseinbalam, Marziyeh, et al.
Publicado: (2023)

Successful Treatment with Bosentan of Lower Extremity Ulcers in a Scleroderma Patient
por: Naert, Alix, et al.
Publicado: (2013)

Gastro-oesophageal reflux disease and eosinophilic oesophagitis: What is the relationship?
por: Wong, Stephanie, et al.
Publicado: (2018)

Sensory Phenotype of the Oesophageal Mucosa in Gastro-Oesophageal Reflux Disease
por: Ustaoglu, Ahsen, et al.
Publicado: (2023)

Short-Term Symptomatic Relief in Gastroesophageal Reflux Disease: A Comparative Study of Esomeprazole and Vonoprazan
por: Sakurai, Kouichi, et al.
Publicado: (2018)

Vonoprazan versus Lansoprazole for the Initial Treatment of Reflux Esophagitis: A Cost-effectiveness Analysis in Japan
por: Habu, Yasuki
Publicado: (2019)

Cost-effectiveness analysis of vonoprazan versus proton pump inhibitors in the treatment of reflux esophagitis in China
por: Wang, Zhenhua, et al.
Publicado: (2022)

Assessments of CYP‑inhibition‑based drug–drug interaction between vonoprazan and poziotinib in vitro and in vivo
por: Zhou, Shan, et al.
Publicado: (2023)

British Society of Gastroenterology guidelines for oesophageal manometry and oesophageal reflux monitoring
por: Trudgill, Nigel J, et al.
Publicado: (2019)

Changes to the upper gastrointestinal microbiotas of children with reflux oesophagitis and oesophageal metaplasia
por: Luu, Laurence D. W., et al.
Publicado: (2022)

YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019)

5-Aminolevulinic Acid Attenuates Glucose-Regulated Protein 78 Expression and Hepatocyte Lipoapoptosis via Heme Oxygenase-1 Induction
por: Hashimoto, Takaaki, et al.
Publicado: (2021)

Bosentan, a drug used in the treatment of pulmonary hypertension, can prevent development of osteoporosis
por: Köse, Duygu, et al.
Publicado: (2021)

Evaluation of commonly used cardiovascular drugs in inhibiting vonoprazan metabolism in vitro and in vivo
por: Wang, Yiran, et al.
Publicado: (2022)

Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data
por: Marabotto, Elisa, et al.
Publicado: (2020)

Vonoprazan in the management of gastric/peptic ulcers: a systematic review of safety data
por: Moraes-Filho, Joaquim Prado P., et al.
Publicado: (2022)

Studies on the Vitrified and Cryomilled Bosentan
por: Minecka, Aldona, et al.
Publicado: (2021)

Gastro-Oesophageal Reflux in Noncystic Fibrosis Bronchiectasis
por: Lee, Annemarie L., et al.
Publicado: (2011)

Is gastro-oesophageal reflux associated with COPD exacerbations?
por: Wedzicha, Jadwiga A.
Publicado: (2013)

Feed thickeners in gastro-oesophageal reflux in infants
por: Kwok, T’ng Chang, et al.
Publicado: (2018)

Reflux symptoms and oesophageal acidification in treated achalasia patients are often not reflux related
por: Ponds, Fraukje A, et al.
Publicado: (2021)

Efficacy of vonoprazan for 24-week maintenance therapy of patients with healed reflux esophagitis refractory to proton pump inhibitors
por: Mizuno, Hideki, et al.
Publicado: (2018)

Randomised clinical trial: vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
por: Ashida, K., et al.
Publicado: (2015)

No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis
por: Hettema, Martha E., et al.
Publicado: (2009)

A thin layer of sucrose octasulfate protects the oesophageal mucosal epithelium in reflux oesophagitis
por: Hayakawa, Takuya, et al.
Publicado: (2019)

Prevalence of gastro-oesophageal reflux disease symptoms and reflux-associated respiratory symptoms in asthma
por: Amarasiri, Lakmali D, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_g6j4fmgrrj7jach1hrn5vsldcm